Jul 11, 2025
IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3
May 27, 2025
IM Cannabis Provides Corporate Updates
May 07, 2025
IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction
May 06, 2025
IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET
Apr 11, 2025
IM Cannabis Provides Corporate Updates
Mar 31, 2025
IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results
Jan 17, 2025
IM Cannabis Announces Change of Auditors
Nov 14, 2024
IM Cannabis Reports Third Quarter Financial Results
Oct 04, 2024
IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management
Aug 14, 2024
IM Cannabis Reports Second Quarter Financial Results
Aug 06, 2024
IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET
Jul 29, 2024
IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement
May 29, 2024
IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany
Apr 16, 2024
IMC to transfer its Oranim Pharmacy shares back to the seller
Mar 28, 2024
IM Cannabis Reports 2023 Financial Results
Mar 25, 2024
IMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis Legalization
Mar 20, 2024
IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET
Jan 31, 2024
IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule
Jan 12, 2024
IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition
Jan 02, 2024
IMC Announces the Conclusion of the Planning and Construction Legal Proceedings